Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin-activated endothelium

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 356, Issue 5, 1997, Pages 529-535

  Dunzendorfer, S ^a   Schratzberger, P ^a   Reinisch, N ^a   Kahler C M ^a   Wiedermann, C J ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Endothelium; Migration; Neutrophils; Thalidomide

Indexed keywords

ENDOTOXIN; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE MIGRATION; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; RESPIRATORY BURST; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; CHEMOTAXIS; CYTOKINES; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; HUMANS; LIPOPOLYSACCHARIDES; NEUTROPHILS; RESPIRATORY BURST; TERATOGENS; THALIDOMIDE;

EID: 0030701896     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005087     Document Type: Article

References (29)

1. Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115:457-469
2. Bone RC (1996) Why sepsis trials fail. JAMA 276:565-566
3. Bone RC (1996b) Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687
4. Condliffe AM, Chilvers ER, Haslett C, Dransfield I (1996) Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 89:105-111
5. Fauré M, Lejeune JP, Gaucherand M, Thivolet J (1981) PMN leukocytes chemotaxis: inhibition by thalidomide. Pathol Biol 29:601-604
6. Förster M, Neubert R (1995) Lack of effects on fetal thymus and lymphocytes development in marmoset fetuses and newborns following treatment with thalidomide. Teratology 51:23A-24A
7. Doll NJ, Barhill RL, Hastings RC, Salvaggio JE, Millikan LE (1983) Thalidomide induced alteration of human peripheral blood monocyte activity. Clin Res 31:920
8. Downey GP, Fialkow L, Fukushima T (1995) Initial interaction of leukocytes within the microvasculature: deformability, adhesion, and transmigration. New Horizons 3:219-228
9. Geitz H, Handt S, Zwingenberger K (1996) Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 31:213-221
10. Hastings RC, Morales MJ (1978) The effect of thalidomide on neutrophil function. Int J Lepr 46:120
11. Keenan RJ, Eiras G, Burckart GJ, Stuart RS, Hardesty RL, Vogelsang G, Griffith BP, Zeevi A (1991) Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. Transplantation 52: 908-910
12. Maier RV, Bulger EM (1996) Endothelial changes after shock and injury. New Horizons 4:211-223
13. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ (1995) Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 23:1638-1652
14. Mellin GW, Katzenstein M (1962) The saga of thalidomide. N Engl J Med 267:1184
15. Miyachi H, Azuma A, Hioli E, Iwasaki S, Kobayashi Y, Hashimoto Y (1996) Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor alpha production. Biochem Biophys Res Commun 224:426-430
16. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177:1675-1680
17. Moser R, Schleiffenbaum B, Groscurth P (1989) Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83:444-455
18. Muller W, Weigel S, Deng X (1993) PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-460
19. Nathan C, Srimal S, Farber C, Sanchez E, Kabbash L, Asch A, Gailit J, Wright SD (1989) Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 intergrins. J Cell Biol 109:1341-1349
20. Partrick DA, Moore FA, Moore EE, Barnett CC, Silliman CC (1996) Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horizons 4:194-210
21. Schleiffenbaum B, Fehr J (1990) The tumor necrosis factor receptor and human neutrophil function. Deactivation and cross-deactivation of tumor necrosis factor-induced neutrophil responses by receptor down-regulation. J Clin Invest 86:184-195
22. Thijs LG, Hack CE (1995) Time course of cytokine levels in sepsis. Intens Care Med 21:S258-S263
23. Wan CP, Myung E, Lau BH (1993) An automated micro-fluorometric assay for monitoring oxidative burst activity of phagocytes. J Immunol Meth 159:131-138
24. Wan CP, Sigh RV, Lau BH (1994) A simple fluorometric assay for the determination of cell numbers. J Immunol Meth 173:265-72
25. Wiedermann CJ, Niedermühlbichler M, Braunsteiner H (1992) Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J Clin Invest 89:1580-1586
26. Wiedermann CJ, Schratzberger P, Kähler CM (1994) Migration of neutrophils across endothelial monolayers is stimulated by treatment of the monolayers with β-endorphin. Brain Behav Immunol 8:270-277
27. Wright SD (1991) Multiple receptors for endotoxin. Curr Opin Immunol 3:83-90
28. Yasui K, Yamazaki M, Miyabayashi M, Tsuno T, Komiyama A (1994) Signal transduction pathway in human polymorphonuclear leukocytes for chemotaxis induced by a chemotactic factor. J Immunol 152:5922-5929
29. Zwingenberger K, Wnendt S (1996) Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations. J Inflamm 46:177-211